Generic Drugs
- All
- News
- Videos
-
Australia's Mayne Pharma Sues India's Sun Pharma Over Patent Infringement
Mayne Pharma has filed a lawsuit against India's Sun Pharma over infringements of patents related to a certain product used for menopause-related vaginal pain, the Australian drugmaker said on Thursday.
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
Mandatory Prescription Of Generic Drugs Rule Put On Hold By Medical Panel
The National Medical Commission (NMC) on Thursday put on hold the regulations that make it mandatory for doctors to prescribe generic drugs and bar them from accepting gifts from pharma companies or endorsing any drug brands.
-
Doctors' Body Seeks Withdrawal Of Mandatory Prescription Of Generic Medicines
The IMA has written to Union Health Minister Mansukh Mandaviya seeking withdrawal of National Medical Commission (NMC) regulations on mandatory prescription of generic drugs till there is quality assurance of all medicines.
-
Defer Implementation Of Rules On Generic Drugs: Doctors' Body To Government
The Indian Medical Association (IMA) on Monday demanded that implementation of regulations that make it mandatory for doctors to prescribe generic drugs be deferred, raising concerns over the standard of drugs manufactured i
-
Doctors To Be Penalised For Failing To Prescribe Generic Drugs, Say Rules
All doctors must prescribe generic drugs, failing which they will be penalised and even their license to practice may also be suspended for a period, according to the new regulations issued by the National Medical Commission.
-
Zydus Gets US Regulator's Approval To Market Generic Drug For Myxedema Coma
Zydus Lifesciences today said it has received approval from the US health regulator to market a generic product which is used to treat myxedema coma.
-
Johnson & Johnson Loses Key Tuberculosis Drug Patent In India
The Indian Patent Office on Thursday rejected US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions.
-
Sun Pharma Recalls Over 34,000 Bottles Of Generic Drug In US After It Fails Test
Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing.
-
Amazon Pharmacy Launches RxPass Prescription Drug Subscription Service for US Prime Members
Amazon Pharmacy on Tuesday announced the launch of its RxPass monthly subscription plan for US Prime members that will cover a range of generic drugs and their doorstep delivery, according to the e-commerce giant. However, customers enrolled in Medicare, Medicaid or any other government healthcare program will not be able to enrol in Amazon Pharmac...
-
Lupin Launches Generic Joint Pain Drug In US
Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of $509 million in the US.
-
Zydus Gets US Regulator's Approval To Market Generic Epilepsy Drug
The drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, Zydus said in a statement.
-
Where to Buy Modafinil: Online Shipping to USA/ Canada/ UK
Modafinil can be described as a prescribed drug and smart drug, which is used for a myriad of uses and treatments. Modafinil is sold under various trade names, which include famous generic brands, and can be purchased through online pharmacies.
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Seizures
Pharmaceuticals firm Lupin Ltd on Thursday said it has received approval from the US health regulator to market its generic rufinamide tablets used in the treatment seizures.
-
Australia's Mayne Pharma Sues India's Sun Pharma Over Patent Infringement
Mayne Pharma has filed a lawsuit against India's Sun Pharma over infringements of patents related to a certain product used for menopause-related vaginal pain, the Australian drugmaker said on Thursday.
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
Mandatory Prescription Of Generic Drugs Rule Put On Hold By Medical Panel
The National Medical Commission (NMC) on Thursday put on hold the regulations that make it mandatory for doctors to prescribe generic drugs and bar them from accepting gifts from pharma companies or endorsing any drug brands.
-
Doctors' Body Seeks Withdrawal Of Mandatory Prescription Of Generic Medicines
The IMA has written to Union Health Minister Mansukh Mandaviya seeking withdrawal of National Medical Commission (NMC) regulations on mandatory prescription of generic drugs till there is quality assurance of all medicines.
-
Defer Implementation Of Rules On Generic Drugs: Doctors' Body To Government
The Indian Medical Association (IMA) on Monday demanded that implementation of regulations that make it mandatory for doctors to prescribe generic drugs be deferred, raising concerns over the standard of drugs manufactured i
-
Doctors To Be Penalised For Failing To Prescribe Generic Drugs, Say Rules
All doctors must prescribe generic drugs, failing which they will be penalised and even their license to practice may also be suspended for a period, according to the new regulations issued by the National Medical Commission.
-
Zydus Gets US Regulator's Approval To Market Generic Drug For Myxedema Coma
Zydus Lifesciences today said it has received approval from the US health regulator to market a generic product which is used to treat myxedema coma.
-
Johnson & Johnson Loses Key Tuberculosis Drug Patent In India
The Indian Patent Office on Thursday rejected US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions.
-
Sun Pharma Recalls Over 34,000 Bottles Of Generic Drug In US After It Fails Test
Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing.
-
Amazon Pharmacy Launches RxPass Prescription Drug Subscription Service for US Prime Members
Amazon Pharmacy on Tuesday announced the launch of its RxPass monthly subscription plan for US Prime members that will cover a range of generic drugs and their doorstep delivery, according to the e-commerce giant. However, customers enrolled in Medicare, Medicaid or any other government healthcare program will not be able to enrol in Amazon Pharmac...
-
Lupin Launches Generic Joint Pain Drug In US
Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of $509 million in the US.
-
Zydus Gets US Regulator's Approval To Market Generic Epilepsy Drug
The drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, Zydus said in a statement.
-
Where to Buy Modafinil: Online Shipping to USA/ Canada/ UK
Modafinil can be described as a prescribed drug and smart drug, which is used for a myriad of uses and treatments. Modafinil is sold under various trade names, which include famous generic brands, and can be purchased through online pharmacies.
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Seizures
Pharmaceuticals firm Lupin Ltd on Thursday said it has received approval from the US health regulator to market its generic rufinamide tablets used in the treatment seizures.
